Overactivation of S6 kinase 1 as a cause of human insulin resistance during increased amino acid availability.

To examine the molecular mechanisms by which plasma amino acid elevation impairs insulin action, we studied seven healthy men twice in random order during infusion of an amino acid mixture or saline (total plasma amino acid approximately 6 vs. approximately 2 mmol/l). Somatostatin-insulin-glucose clamps created conditions of low peripheral hyperinsulinemia ( approximately 100 pmol/l, 0-180 min) and prandial-like peripheral hyperinsulinemia ( approximately 430 pmol/l, 180-360 min). At low peripheral hyperinsulinemia, endogenous glucose production (EGP) did not change during amino acid infusion but decreased by approximately 70% during saline infusion (EGP(150-180 min) 11 +/- 1 vs. 3 +/- 1 mumol . kg(-1) . min(-1), P = 0.001). Prandial-like peripheral hyperinsulinemia completely suppressed EGP during both protocols, whereas whole-body rate of glucose disappearance (R(d)) was approximately 33% lower during amino acid infusion (R(d) (330-360 min) 50 +/- 4 vs. 75 +/- 6 mumol . kg(-1) . min(-1), P = 0.002) indicating insulin resistance. In skeletal muscle biopsies taken before and after prandial-like peripheral hyperinsulinemia, plasma amino acid elevation markedly increased the ability of insulin to activate S6 kinase 1 compared with saline infusion ( approximately 3.7- vs. approximately 1.9-fold over baseline). Furthermore, amino acid infusion increased the inhibitory insulin receptor substrate-1 phosphorylation at Ser312 and Ser636/639 and decreased insulin-induced phosphoinositide 3-kinase activity. However, plasma amino acid elevation failed to reduce insulin-induced Akt/protein kinase B and glycogen synthase kinase 3alpha phosphorylation. In conclusion, amino acids impair 1) insulin-mediated suppression of glucose production and 2) insulin-stimulated glucose disposal in skeletal muscle. Our results suggest that overactivation of the mammalian target of rapamycin/S6 kinase 1 pathway and inhibitory serine phosphorylation of insulin receptor substrate-1 underlie the impairment of insulin action in amino acid-infused humans.

[1]  W. A. Müller,et al.  Studies of pancreatic alpha cell function in normal and diabetic subjects. , 1970, The Journal of clinical investigation.

[2]  S. Adibi.  Metabolism of branched-chain amino acids in altered nutrition. , 1976, Metabolism: clinical and experimental.

[3]  G. Freund,et al.  Vanadate and rapamycin synergistically enhance insulin-stimulated glucose uptake. , 2003, Metabolism: clinical and experimental.

[4]  R. Henry,et al.  Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes. , 1999, The Journal of clinical investigation.

[5]  J. Olefsky,et al.  A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1. , 2000, Molecular endocrinology.

[6]  F. Nuttall,et al.  Metabolic response of people with type 2 diabetes to a high protein diet , 2004, Nutrition & metabolism.

[7]  A. Schiffrin,et al.  Effects of dietary protein restriction on glucose and insulin metabolism in normal and diabetic humans. , 1994, Metabolism: clinical and experimental.

[8]  M. Roden,et al.  Direct and indirect effects of amino acids on hepatic glucose metabolism in humans , 2003, Diabetologia.

[9]  R. DeFronzo.  The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM , 1988, Diabetes.

[10]  C. Cobelli,et al.  Alterations in postprandial hepatic glycogen metabolism in type 2 diabetes. , 2004, Diabetes.

[11]  J. Livingston,et al.  Regulation of rat glucagon receptor expression. , 1994, Biochemical and biophysical research communications.

[12]  Johan Auwerx,et al.  Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity , 2004, Nature.

[13]  R. Moxley,et al.  Metabolism of Forearm Tissues in Man: Studies with Glucagon , 1976, Diabetes.

[14]  J. E. Felíu,et al.  The Hormonal Control of Pyruvate Kinase Activity and of Gluconeogenesis in Isolated Hepatocytes , 1976 .

[15]  D. Mercer,et al.  Protein digestion in human intestine as reflected in luminal, mucosal, and plasma amino acid concentrations after meals. , 1973, The Journal of clinical investigation.

[16]  A. Marette,et al.  Amino acid and insulin signaling via the mTOR/p70 S6 kinase pathway. A negative feedback mechanism leading to insulin resistance in skeletal muscle cells. , 2001, The Journal of biological chemistry.

[17]  Hiroshi Sakaue,et al.  Modulation of Insulin-stimulated Degradation of Human Insulin Receptor Substrate-1 by Serine 312 Phosphorylation* , 2003, The Journal of Biological Chemistry.

[18]  R. Geyer,et al.  Effect of dietary protein intake on insulin secretion and glucose metabolism in insulin-dependent diabetes mellitus. , 1996, The Journal of clinical endocrinology and metabolism.

[19]  O. Shah,et al.  4E-BP1 and S6K1: translational integration sites for nutritional and hormonal information in muscle. , 2000, American journal of physiology. Endocrinology and metabolism.

[20]  T. Valle,et al.  Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. , 2001, The New England journal of medicine.

[21]  R G Shulman,et al.  Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. , 1990, The New England journal of medicine.

[22]  D. Grönemeyer,et al.  Effect of long-term dietary protein intake on glucose metabolism in humans , 2000, Diabetologia.

[23]  Nutrition in Germany , 1947, British medical journal.

[24]  C. Rondinone,et al.  Serine/threonine phosphorylation of IRS-1 triggers its degradation: possible regulation by tyrosine phosphorylation. , 2001, Diabetes.

[25]  L. Schmetterer,et al.  Increased plasma levels of plasminogen activator inhibitor-1 and soluble vascular cell adhesion molecule after triacylglycerol infusion in man , 2003, Thrombosis and Haemostasis.

[26]  Peter Nowotny,et al.  Mechanism of amino acid-induced skeletal muscle insulin resistance in humans. , 2002, Diabetes.

[27]  S. Fowler,et al.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002 .

[28]  S. Fajans,et al.  Stimulation of insulin secretion by amino acids. , 1966, The Journal of clinical investigation.

[29]  S. Mudaliar,et al.  Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes. , 2000, Diabetes.

[30]  E. Roth,et al.  Postoperative glycyl-glutamine infusion reduces immunosuppression: partial prevention of the surgery induced decrease in HLA-DR expression on monocytes. , 2001, Clinical nutrition.

[31]  A. Marette,et al.  Defective insulin-induced GLUT4 translocation in skeletal muscle of high fat-fed rats is associated with alterations in both Akt/protein kinase B and atypical protein kinase C (zeta/lambda) activities. , 2001, Diabetes.

[32]  K. Petersen,et al.  Effect of epinephrine on muscle glycogenolysis and insulin-stimulated muscle glycogen synthesis in humans. , 1998, American journal of physiology. Endocrinology and metabolism.

[33]  P. Cohen,et al.  Specificity and mechanism of action of some commonly used protein kinase inhibitors. , 2000, The Biochemical journal.

[34]  J. Manson,et al.  Processed meat intake and incidence of Type 2 diabetes in younger and middle-aged women , 2003, Diabetologia.

[35]  C. Kahn,et al.  Bidirectional modulation of insulin action by amino acids. , 1998, The Journal of clinical investigation.

[36]  M. Davidson,et al.  Protein and fat effects on glucose responses and insulin requirements in subjects with insulin-dependent diabetes mellitus. , 1993, The American journal of clinical nutrition.

[37]  W. Waldhäusl,et al.  Combined 17 alpha- and 18-hydroxylase deficiency associated with complete male pseudohermaphroditism and hypoaldosteronism. , 1978, The Journal of clinical endocrinology and metabolism.

[38]  M. Roden.  How free fatty acids inhibit glucose utilization in human skeletal muscle. , 2004, News in physiological sciences : an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society.

[39]  T. B. Miller,et al.  The hormonal control of hepatic gluconeogenesis. , 1970, Recent progress in hormone research.

[40]  D. Hardie,et al.  Increased phosphorylation of skeletal muscle glycogen synthase at NH2-terminal sites during physiological hyperinsulinemia in type 2 diabetes. , 2003, Diabetes.

[41]  A. Marette,et al.  Defective Insulin-Induced GLUT4 Translocation in Skeletal Muscle of High Fat–Fed Rats Is Associated With Alterations in Both Akt/Protein Kinase B and Atypical Protein Kinase C (ζ/λ) Activities , 2001 .

[42]  G. Shulman,et al.  Lipid-dependent control of hepatic glycogen stores in healthy humans , 2001, Diabetologia.

[43]  M. Roden,et al.  Nutrient-induced insulin resistance in human skeletal muscle. , 2004, Current medicinal chemistry.

[44]  M. Roden,et al.  Free fatty acids inhibit the glucose-stimulated increase of intramuscular glucose-6-phosphate concentration in humans. , 2001, The Journal of clinical endocrinology and metabolism.

[45]  Anson,et al.  DIET , LIFESTYLE , AND THE RISK OF TYPE 2 DIABETES MELLITUS IN WOMEN , 2001 .